Hong DG - Search Results

1

Does Carboplatin Rapid Desensitization Change Its Adverse Drug Reactions Other than Hypersensitivity and Efficacy in Patients With Ovarian Cancer?

Park HK, Lee SJ, Kim S, Lee JM, Hong DG. Park HK, et al. Among authors: hong dg. Allergy Asthma Immunol Res. 2020 Nov;12(6):1046-1059. doi: 10.4168/aair.2020.12.6.1046. Allergy Asthma Immunol Res. 2020. PMID: 32935494 Free PMC article.

2

Differential MicroRNA Expression Profiles in Primary and Recurrent Epithelial Ovarian Cancer.

Chong GO, Jeon HS, Han HS, Son JW, Lee YH, Hong DG, Lee YS, Cho YL. Chong GO, et al. Among authors: hong dg. Anticancer Res. 2015 May;35(5):2611-7. Anticancer Res. 2015. PMID: 25964536

3

Applicability of the Histoculture Drug Response Assay to Predict Platinum Sensitivity and Prognosis in Ovarian Cancer.

Lee J, Kim JM, Lee YH, Chong GO, Hong DG. Lee J, et al. Among authors: hong dg. Anticancer Res. 2021 Dec;41(12):6287-6292. doi: 10.21873/anticanres.15450. Anticancer Res. 2021. PMID: 34848485

4

Correlation Between Clinical Outcomes and Serum CA-125 Levels After Standard Treatment for Epithelial Ovarian Cancer.

Lee J, Kim JM, Lee YH, Chong GO, Hong DG. Lee J, et al. Among authors: hong dg. Anticancer Res. 2022 Jan;42(1):349-353. doi: 10.21873/anticanres.15492. Anticancer Res. 2022. PMID: 34969744

5

Survival Outcomes With Reduced Doses of Adjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer.

Lee J, Kim JM, Lee YH, Chong GO, Hong DG. Lee J, et al. Among authors: hong dg. In Vivo. 2022 Jul-Aug;36(4):1868-1874. doi: 10.21873/invivo.12905. In Vivo. 2022. PMID: 35738591 Free PMC article.

6

Comparison of Survival Outcomes According to BRCA1/2 Variant Type in High-grade Serous Ovarian Cancer.

Lee J, Kim JM, Lee YH, Chong GO, Lee NY, Lee IH, Park JY, Hong DG. Lee J, et al. Among authors: hong dg. In Vivo. 2022 Jul-Aug;36(4):1903-1910. doi: 10.21873/invivo.12910. In Vivo. 2022. PMID: 35738605 Free PMC article.

7

Does protracted chemotherapy have an influence on the clinical outcomes in advanced epithelial ovarian cancer?

Lee J, Hong DG. Lee J, et al. Among authors: hong dg. Medicine (Baltimore). 2022 Aug 12;101(32):e29967. doi: 10.1097/MD.0000000000029967. Medicine (Baltimore). 2022. PMID: 35960085 Free PMC article.

8

Comparison of Survival Outcomes Based on Pre-treatment Pleural Effusion in Advanced Epithelial Ovarian Cancer.

Lee J, Hong DG. Lee J, et al. Among authors: hong dg. Anticancer Res. 2022 Oct;42(10):4937-4943. doi: 10.21873/anticanres.16000. Anticancer Res. 2022. PMID: 36191974

9

Laparoscopic second look operation for ovarian cancer: single center experiences.

Hong DG, Park NY, Chong GO, Cho YL, Park IS, Lee YS. Hong DG, et al. Minim Invasive Ther Allied Technol. 2011 Dec;20(6):346-51. doi: 10.3109/13645706.2011.556648. Epub 2011 Mar 17. Minim Invasive Ther Allied Technol. 2011. PMID: 21413836

10

Hyperthermic intrathoracic chemotherapy with cisplatin for ovarian cancer with pleural metastasis.

Jun SY, Seok YK, Kato T, Chun DS, Lee YH, Chong GO, Lee YS, Cho YL, Hong DG. Jun SY, et al. Among authors: hong dg. Obstet Gynecol Sci. 2017 May;60(3):308-313. doi: 10.5468/ogs.2017.60.3.308. Epub 2017 May 15. Obstet Gynecol Sci. 2017. PMID: 28534018 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters